BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1950720)

  • 1. Copper IUDs, PID, and fertility in nulliparous women.
    Struthers BJ
    Adv Contracept; 1991; 7(2-3):211-30. PubMed ID: 1950720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis.
    O'Brien FB; Stewart WC; Sturtevant FM
    Contraception; 1983 Feb; 27(2):111-22. PubMed ID: 6851553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low risk of pelvic inflammatory disease in young never-pregnant women using Gravigard.
    Larsson B; Hagström B; Viberg L; Anker C; Hamberger L; Lindhe BA
    Contraception; 1979 Sep; 20(3):291-5. PubMed ID: 509955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
    Malhotra N; Chaudhury RR
    Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine devices and pelvic inflammatory disease: an international perspective.
    Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
    Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine contraceptive device and pelvic inflammatory disease.
    Toivonen J
    Ann Med; 1993 Apr; 25(2):171-3. PubMed ID: 8489756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the use of intrauterine devices in nulliparous women.
    Graham S; Simcock BW
    Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine contraceptive device use and pelvic inflammatory disease.
    Kaufman DW; Shapiro S; Rosenberg L; Monson RR; Miettinen OS; Stolley PD; Slone D
    Am J Obstet Gynecol; 1980 Jan; 136(2):159-62. PubMed ID: 7352496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
    Buchan H; Villard-Mackintosh L; Vessey M; Yeates D; McPherson K
    Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the association between intrauterine devices and acute pelvic inflammatory disease.
    Ory HW
    J Reprod Med; 1978 Apr; 20(4):200-4. PubMed ID: 353272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intrauterine devices in nulliparous women.
    Lohr PA; Lyus R; Prager S
    Contraception; 2017 Jun; 95(6):529-537. PubMed ID: 27591814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B; Rodau S; Patek E
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of the intrauterine device in nulliparous and parous women.
    Veldhuis HM; Vos AG; Lagro-Janssen AL
    Eur J Gen Pract; 2004 Sep; 10(3):82-7. PubMed ID: 15534571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
    Roy S; Azen C
    Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device.
    Booth M; Beral V; Guillebaud J
    Br Med J; 1980 Jul; 281(6233):114. PubMed ID: 7427204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five years private practice experience of nulliparous women using copper IUD's.
    Smith RP; Goresky DM; Etchell DM
    Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic inflammatory disease and the intrauterine contraceptive device.
    Wright EA; Aisien AO
    Int J Gynaecol Obstet; 1989 Feb; 28(2):133-6. PubMed ID: 2563699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic inflammatory disease in intrauterine device users.
    Beerthuizen RJ
    Eur J Contracept Reprod Health Care; 1996 Sep; 1(3):237-43. PubMed ID: 9678122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrauterine devices and pelvic inflammatory disease: evolving perspectives on the data.
    Burkman RT
    Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S35-41. PubMed ID: 8972501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine contraception in nulligravid vs parous women.
    Dueñas JL; Albert A; Carrasco F
    Contraception; 1996 Jan; 53(1):23-4. PubMed ID: 8631185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.